 Platelets are potent mediators of brain function  Platelets regulate neural cells and contribute to brain plasticity  Platelets carry pro-neurogenic factors  Multiple mechanisms must be considered for platelet-neural cell communication
Introduction
For many years, the brain was considered an immune-privileged site, with neuroimmune crosstalk between brain cells and blood cells thought to be unlikely under normal conditions. However, emerging evidence demonstrates that neuro-immune interactions play an important role in maintaining brain health and plasticity throughout life. Platelets, the smallest cells in our blood, have been gaining recognition for their extensive functional contributions beyond wound healing, with recent work suggesting that these cells may facilitate communication between the blood and the brain. Below we review alternative platelet functions and discuss how these blood cells could contribute to the maintenance of brain homeostasis.
J o u r n a l P r e -p r o o f
In order to fulfil a specific function, platelets must first be activated. The term "platelet activation" is used to describe numerous processes, with the most common platelet responses to activation involving changes in shape, up-regulation of distinct surface molecules, protein synthesis from mRNA and exocytosis, as well as the release of granule contents. In particular, the specific release of molecules from small secretory vesicles represents a mechanism via which processes beyond the blood-brain barrier, which tightly controls the passage of large molecules and cells between the blood and brain tissue, can be regulated. Different protein secretion profiles have been described in response to stimulation with the three common platelet agonists, adenosine diphosphate, thrombin receptor-activating peptide and collagen, indicating that platelets can exert different regulatory functions depending on their mode of stimulation (Coppinger et al., 2007) . Another study confirmed that distinct subpopulations of α-granules exist, in which proteins are stored in specific clusters, including pro-or anti-angiogenic protein clusters (Italiano et al., 2008) . More specifically, the authors demonstrated that the release of the granule subtypes was selective and triggered by the stimulation of different receptors with specific agonists, suggesting that α-granule contents can be locally released to either stimulate or inhibit angiogenesis as required (Italiano et al., 2008) . Inflammation also increased the number of activated platelets in the blood; however, thrombus formation and the accumulation of platelets on the endothelial surface, as seen in wound healing, were not observed, indicating that immune activation represents another distinct mode of platelet activation (Imhof et al., 2016) . Moreover, increased platelet activation, as measured by higher levels of the cytokine CD40L, was observed in chronic hypertensive rats, in which more platelets were also observed in brain microvessels (Bhat et al., 2017) . In a recent study we found more activated platelets in the blood of mice that performed voluntary exercise for four days compared to sedentary mice (Leiter et al., 2019) , a paradigm which increases the proliferation of neural precursor cells in the hippocampal dentate gyrus (Overall et al., 2013) . The proteomic signature of platelets following exercise did not include classical platelet activation markers, such as activation-specific glycoprotein IIb/IIIa receptors (Niiya et al., 1987) , which also regulate the release of soluble platelet CD40L (Furman et al., 2004) , suggesting that exercise-induced platelet activation represents yet another distinct form of activation (Leiter et al., 2019) . However, studies to date have only started to reveal the J o u r n a l P r e -p r o o f complexity of platelet activation and the specificity of responses, including their implication in brain regulation.
The immune actions of plateletsimplications for brain function?
The role of platelets in mediating peripheral immune responses is becoming increasingly recognized (Ali et al., 2015; Lam et al., 2015) , with the activation-induced up-regulation of a large receptor and molecule repertoire allowing platelets to interact with almost every type of immune cell (Yun et al., 2016) . Apart from the up-regulation of surface molecules to mediate immune responses, activated platelets also secrete a vast range of pro-and/ or anti-inflammatory mediators (Ali et al., 2015; Semple et al., 2011) . Recent work has shown that platelets are required for early immune responses in the periphery, such as the initiation of inflammation after viral infection (Imhof et al., 2016) . The authors demonstrated that platelets recruit neutrophils and monocytes to the infected tissue through the release of the protein CCN1 (Imhof et al., 2016) , making them an integral part of the immune system. Furthermore, it was shown that activated platelets autonomously and actively migrate through the blood stream and bundle bacteria, promoting neutrophil activation (Gaertner et al., 2017) , which demonstrates an essential role of platelets in innate immune responses. Earlier proteomic studies identified essential immune function-related proteins among the molecules secreted by platelets, including interleukin-1, major histocompatibility complex molecules and CD40L (Coppinger et al., 2007 (Coppinger et al., , 2004 May et al., 2002; Zufferey et al., 2014) , underpinning their role in immune function.
It is also becoming clear that peripheral immune factors contribute to the maintenance of brain function; however, the immune actions of platelets in this context are only beginning to gain attention. Platelets carry immune molecules that have been reported to influence brain function, including transforming growth factor-ß (Kandasamy et al., 2014) , ß-2 microglobulin (Smith et al., 2015) and gelsolin (Kronenberg et al., 2010) .
They have also been shown to contribute to the activation of cortical microglia via activated inflammatory monocytes and monocyte-platelet aggregates that form in the blood of mice following liver inflammation, a condition that also affects sickness behaviors including depression, fatigue and cognitive impairments (D'Mello et al., 2017) . Moreover, an increased number of platelets was found in the brain J o u r n a l P r e -p r o o f microvasculature of rats in a model of chronic hypertension, a condition that changes the expression of adhesion molecules in the cerebral microvessels, including VCAM-1, ICAM-1 and JAM-1, which are associated with accumulation of platelets (Bhat et al., 2017) . In the same study, platelet-derived CD40L was shown to induce neuroinflammation and neuronal death in the hippocampus and cortex (Bhat et al., 2017) , regions that are both implicated in memory function. Interestingly, the plateletinduced astrogliosis and microgliosis, and thus the subsequent cell death in those brain regions of the hypertensive rats was ameliorated by clopidogrel, an anti-platelet drug also commonly used in humans (Bhat et al., 2017) .
Another interesting link between platelet immune function and brain regulation is the complement system. Upon activation, platelets release complement component 3 (C3) and other complement factors (Coppinger et al., 2004; del Conde et al., 2005; Peerschke et al., 2006) . Complement fragment receptors, such as the complement fragments C3a and C5a that result from cleavage of C3 and C5, are also expressed on neural precursor cells of the adult hippocampus (Rahpeymai et al., 2006) . However, whether C3a derived from C3 of activated platelets modulates neural precursor cells or other neural cell types remains to be determined.
Platelets drive tissue remodeling and regeneration
Platelets are also emerging as important players in the field of regenerative medicine.
Following tissue injury and inflammation, platelets contribute to tissue remodeling across many tissues, with applications including the support of cartilage repair (Kavadar et al., 2015) , and the healing of injured tendons (Dragoo et al., 2014) and skin (Ozcelik et al., 2016) . The complexity of platelet responses to tissue damage has been recently highlighted in a review article by Eisinger et al. 2018 , including the induction of apoptosis, initiation of immune responses and recruitment of progenitor cells to the sites of injury to promote tissue remodeling. Moreover, the potential contribution of platelets to central nervous system (CNS) repair has been reviewed previously and will be summarized below. Platelets are an abundant source of growth factors, such as platelet-derived growth factor, brainderived neurotrophic factor, platelet factor 4 (PF4), transforming growth factor-ß, insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), J o u r n a l P r e -p r o o f 7 epidermal growth factor, fibroblast growth factor-2 (FGF-2), hepatocyte growth factor, connective tissue growth factor and bone morphogenetic protein-2, -4 and -6, indicating a significant role of platelets for tissue growth and regeneration, including in the brain (Burnouf et al., 2016; Golebiewska and Poole, 2015; Stellos et al., 2010) .
Platelet-released factors have been shown to recruit other cell types to injured areas and promote site-specific regeneration. As an example, platelet-derived FGF-2 promotes the adhesion of mesenchymal stem cells to endothelial cells and fosters their proliferation, as well as their integration into the endothelial cell layer (Langer et al., 2009 ), suggesting a fundamental role of platelets and their derived factors in orchestrating vascular regeneration. FGF-2 was shown to have neuroprotective effects in the adult hippocampus following traumatic brain injury, suggesting a role in regeneration and protection (Yoshimura et al., 2003) . Whether platelets contribute to regeneration following brain injury by the release of factors, such as FGF-2, is unknown. However, platelets can recruit circulating progenitor cells through the secretion of stromal cell-derived factor 1- (SDF-1-) to the sites of vascular injury (Massberg et al., 2006) and can promote their differentiation into endothelial cells Langer et al., 2006) . Similarly, SDF-1- has also been shown to be involved in regenerative processes in neural tissue, where it promotes the migration of neural precursor cells towards damaged areas following stroke (Imitola et al., 2004) .
Although the authors suggested that astrocytes and endothelial cells act as the sources of increased SDF1- expression after injury (Imitola et al., 2004) , SDF1- derived from platelets could also contribute to this repair.
Apart from hemostasis, inflammation and angiogenesis, another essential aspect of tissue repair following tissue damage is controlled apoptosis. Activated platelets express the death receptor Fas ligand FasL on their surface, through which they can induce apoptosis in damaged cells (Ahmad et al., 2001; Schleicher et al., 2015) . FasLinduced apoptosis has previously been shown to serve as a controlled way to eliminate inflammation and prevent spreading of inflammatory responses within the eye (Griffith et al., 1995) . Blocking FasL and platelet depletion both led to a decrease in apoptosis of neuronal tissue in models of retinal inflammation and stroke, suggesting that platelets are an important contributor to the prevention of uncontrolled cell death across tissues including the brain (Schleicher et al., 2015) . However, despite the J o u r n a l P r e -p r o o f accumulating evidence that platelets play an important role in tissue repair, the precise mechanisms underlying the restorative effects of platelets on neural cells in tissue remodeling and regeneration remain to be determined.
Plateletsunexpected mediators of brain plasticity
The brain has a remarkable ability to reorganize itself throughout life in order to adapt to environmental diversity. One way in which the adult brain can retain its plasticity is via the continuous generation of new functional neurons derived from neural precursor cells. This process, known as adult neurogenesis, occurs in specialized neurogenic niches in the brain of most mammals, predominantly in the subgranular zone of the hippocampal dentate gyrus and in the subventricular zone (SVZ) of the lateral ventricles. The hippocampus is a critical region for learning and memory and impairments in hippocampal neurogenesis are associated with deficits in spatial learning and cognitive function (Clelland et al., 2009; Dupret et al., 2008; Garthe et al., 2009 Garthe et al., , 2014 . Despite one recent study (Sorrells et al., 2018) , strong evidence exists that neurogenesis also occurs in the hippocampus of adult humans (Boldrini et al., 2018; Eriksson et al., 1998; Moreno-Jiménez et al., 2019; Spalding et al., 2013; Tobin et al., 2019) , highlighting the relevance of this process.
The neurogenic niches are well vascularized and although the exchange of selected molecules between the circulation and the nervous system at the blood-brain interface is tightly controlled, potential interactions with blood-borne factors and neural precursor cells are likely. Neurogenesis occurs in angiogenic niches, with neural stem and progenitor cells directly contacting the blood vessels ( Figure 1 ; Filippov et al., 2003; Mirzadeh et al., 2008; Moss et al., 2016; Palmer et al., 2000; Sun et al., 2015; Tavazoie et al., 2008) . Recent work has demonstrated that blood-borne factors influence neurogenesis in pathological as well as physiological conditions, including during normal aging (Castellano et al., 2017; Villeda et al., 2014 Villeda et al., , 2011 . Neurogenesis in aged mice was promoted when these mice shared their blood circulation with that of young mice, whereas neurogenesis in the young mice was decreased (Villeda et al., 2014 (Villeda et al., , 2011 , indicating differing neurogenesis-influencing molecules in the blood of aged and young mice. Moreover, the same authors reported that immune proteins from the plasma of young individuals were able to promote neurogenesis and enhance J o u r n a l P r e -p r o o f hippocampal function in aged mice (Castellano et al., 2017; Villeda et al., 2014 Villeda et al., , 2011 .
We propose that this process is mediated by platelet-derived proteins in the plasma.
Platelet -granules carry a range of bioactive molecules that have been shown to promote neurogenesis independently of their secretion by platelets. These include VEGF (Jin et al., 2002) , epidermal growth factor (Reynolds and Weiss, 1992) , FGF-2 (Palmer et al., 1995; Rai et al., 2007) , IGF-1 (Nieto-Estévez et al., 2016), PF4 (Leiter et al., 2019) , transforming growth factor-ß (Kandasamy et al., 2014) and SDF-1 (Imitola et al., 2004) . Furthermore, platelets store neurogenesis-promoting molecules, such as serotonin (Banasr et al., 2004) and histamine (Wasielewska et al., 2017) , in dense granules, and a number of studies have demonstrated that platelets and the factors which they release modulate neural precursor cell biology in the adult dentate gyrus (Leiter et al., 2019) and in the SVZ (Hayon et al., 2013 (Hayon et al., , 2012a (Hayon et al., , 2012b Kazanis et al., 2015) . Despite their repertoire of regulatory functions and the abundant neurogenesis-promoting molecules they carry, little is known about the role of platelets in the regulation of neurogenesis. In embryonic brain tissue, platelet microparticles (PMPs) promote neural precursor cell proliferation, survival and differentiation into neurons in vitro (Hayon et al., 2012b) . Further evidence highlighting the role of platelets in neural precursor cell regulation is described in the following paragraphs and is summarized in Table 1.
Platelets mediate SVZ neurogenesis
The beneficial effects of platelets and platelet-derived factors on neurogenesis in the adult SVZ have been primarily studied in the context of injury. Following cerebral ischemia, PMPs promote neurogenesis in vivo in the SVZ of adult rats (Hayon et al., 2012a) . Neuroprotective effects in rats following stroke were also observed after an intracerebroventricular injection of platelet lysate, indicating that platelet-derived molecules can mediate such effects (Hayon et al., 2013) . Moreover, the rats that received a platelet lysate injection exhibited more proliferating cells and more new neurons in the SVZ (Hayon et al., 2013) . In addition to cellular effects, the platelet lysate-treated animals displayed improved behavioral outcomes, as evaluated by a J o u r n a l P r e -p r o o f lower neurologic severity score two to three weeks after the onset of the injury, suggesting that this improvement could be due to the increase in neurogenesis (Hayon et al., 2013) . In another study, platelet lysate treatment reduced apoptosis and promoted the survival of proliferating SVZ-derived neural precursor cells . Following demyelination, the accumulation of platelets at the sites of proliferating neural precursor cells has also been associated with increased neural precursor cell survival in these areas . However, under physiological conditions the treatment of SVZ-derived primary cells with platelet-rich plasma (PRP) had no effect on the proliferation or differentiation potential of neural precursor cells (Leiter et al., 2019) , indicating that platelets promote SVZ neurogenesis primarily to facilitate CNS repair following injury.
Platelets mediate dentate gyrus neurogenesis
Neurogenesis in the hippocampal dentate gyrus is associated with learning and memory, and the neural precursor cells in this niche are responsive to environmental stimuli such as environmental enrichment and physical exercise. However, it is unknown how systemic changes are communicated to the neural precursor cells. We recently reported that PRP treatment of primary cells isolated from the dentate gyrus increased neural precursor cell proliferation and promoted neuronal differentiation (Leiter et al., 2019) . In the developing brain, it has been shown that the proliferation of sonic hedgehog (shh)-responsive stem cells is dependent on platelets, which transport epithelial shh to the dentate gyrus, indicating a direct interaction of platelets with glial cells at the perinatal vessel wall (Choe et al., 2015) . Neural stem cells in the adult dentate gyrus originate from shh-responsive progenitor cells in the ventral hippocampus . Moreover, shh signaling is important for the maintenance and proliferation of adult neural stem cells in both the dentate gyrus and the SVZ (Machold et al., 2003) . The source of shh in the adult neurogenic niches is unclear and it remains to be determined whether shh and other factors that could be delivered by platelets contribute to the regulation of neural precursor cells in the adult brain.
Physical exercise is one of the strongest physiological mediators of hippocampal neural precursor cell proliferation (van Praag et al., 1999) . Exercise selectively J o u r n a l P r e -p r o o f increases cerebral blood volume in the dentate gyrus, which positively correlates with neurogenesis in mice and with fitness and cognitive performance in humans (Pereira et al., 2007) . In addition, physical activity leads to increased vascular density in the hippocampal microvasculature that is associated with neural precursor cell proliferation (Van der Borght et al., 2009 ) and can be mediated through runninginduced changes in the systemic environment. We recently found that platelets contribute to the running-induced increase in neural precursor cell proliferation in vivo, with mice failing to exhibit this increase following platelet depletion (Leiter et al., 2019) .
Platelets carry molecules that have been shown to be required for the running-induced increase in precursor cell proliferation in the dentate gyrus, including serotonin (Klempin et al., 2013) , peripheral VEGF (Fabel et al., 2003) and IGF1 (Trejo et al., 2001 ), suggesting that platelets could act as a messenger to communicate these exercise-induced systemic changes to the brain. However, physical activity results in a range of changes, not only in the blood but also in other tissues. For example, cathepsin B, which is released from muscle tissue, has been shown to have runninginduced neurogenic effects, leading to improved spatial memory (Moon et al., 2016) .
Platelets potentially act as vehicles to communicate these changes to the neurogenic niche, but the modes of action of neural precursor cell-platelet crosstalk remain unclear.
Platelets mediate synaptic plasticity
Another way in which the brain can retain plasticity is at the level of the synapse.
Platelets have recently been shown to influence synaptic plasticity following traumatic brain injury by stimulating neuronal activity and increasing the survival of neurons near the site of injury (Dukhinova et al., 2018) . In addition, platelet-derived serotonin increased the expression of the immediate early genes cFos, Arc and Egr1 and the synaptic plasticity genes PSD95, Bdnf and TrkB, increased the number of mature spines and increased neuronal electrophysiological activity in in vitro cortical neuron cultures (Dukhinova et al., 2018) . A much earlier study showed that platelet-activating factor induced hippocampal long-term potentiation, a form of synaptic plasticity that is associated with learning and memory processes (Wieraszko et al., 1993) . However, given that platelet-activating factor is produced by a number of cell types, this effect cannot be directly attributed to platelets. Angiogenesis is a well-balanced complex process by which new capillaries are formed and sprout from pre-existing vessels. Platelets represent one of the largest sources of angiogenic regulators (Folkman et al., 2001) , with platelet-derived molecules regulating angiogenesis at different stages of this process (Brill et al., 2004) and having both pro-and anti-angiogenic effects (Italiano et al., 2008) . Angiogenesis and neurogenesis appear to be tightly coupled in the adult dentate gyrus (Palmer et al., 2000) , making the angiogenesis-promoting capacities of platelets an interesting feature to consider in the context of neural precursor cell regulation. Although not a prerequisite for angiogenic vessel formation, platelet-mediated angiogenesis is mainly promoted by the release of factors from-granules (Kisucka et al., 2006) .
Interestingly, many pro-angiogenic factors released from -granules also have pro- (Palmer et al., 1995; Rai et al., 2007) . Another platelet-derived -granule molecule that can regulate both angiogenesis and neurogenesis is thrombospondin-1 (TSP-1).
The actions of TSP-1 in regulating angiogenesis are mainly anti-angiogenic and have been reviewed by others (Lawler and Lawler, 2012; Mirochnik et al., 2008) . However, depending on its interaction with different molecules (Resovi et al., 2014) , such as Itga9/Itgb1 integrin (Staniszewska et al., 2007) , TSP-1 can also have angiogenesisstimulating actions. Both the Itga9 and Itgb1 integrin subunits are also expressed on neural precursor cells (Campos et al., 2004; Hall et al., 2006; Kazanis et al., 2010) .
Although the function of Itga9 in neural precursor cells remains largely unknown, Itgb1
has been shown to be important for various processes, such as the survival, maintenance, proliferation, migration and differentiation of neural precursor cells in the embryonic and adult brain (Campos et al., 2004; Flanagan et al., 2006; Kazanis et al., 2010; Staquicini et al., 2009 ). Thus, platelet-derived TSP-1 could be involved in promoting these processes via the Itga9/Itgb1 integrin complex. In support of this notion, TSP-1 has been shown to be important for adult neurogenesis, with mice lacking TSP-1 exhibiting a significant reduction in proliferation and neuronal J o u r n a l P r e -p r o o f differentiation in both the SVZ and the subgranular zone (Lu and Kipnis, 2010) . This deficit could be rescued in vitro, with the addition of recombinant TSP-1 to primary cells derived from the adult SVZ resulting in an increased proliferation potential and more cells differentiating into neurons (Lu and Kipnis, 2010) . Although the authors focused on astrocytes as the source of exogenous TSP-1, platelet-derived TSP-1 could likewise lead to the neurogenesis-promoting effects on neural precursor cells.
Mechanisms via which platelets could communicate with neural cells
It is clear that platelets are involved in regulating CNS processes. We have recently shown that PRP acts directly on a pure population of flow cytometry-isolated neural precursor cells in vitro, without the support of other cell types (Leiter et al., 2019) .
Although the direct secretion of bioactive molecules from dense and -granules represents a likely avenue of intercellular communication, additional mechanisms via which platelets may facilitate crosstalk between the periphery and the brain should be considered (see Figure 2 ).
Platelets release microparticles
The brain is spanned by a dense network of fine microvasculature. Therefore, one mechanism via which platelets could communicate with neural cells is the packaging and transportation of molecules by small extracellular vesicles. In recent years, extracellular vesicles have been emerging as an important mechanism of intercellular communication. The majority of extracellular vesicles in the blood (60 to 90%) are platelet-derived, as determined by expression of the marker CD41 (Brisson et al., 2017) . Resting platelets constitutively produce extracellular vesicles (Cauwenberghs et al., 2006) . However, platelet activation increases the number of platelet-derived extracellular vesicles, and their molecular cargo can be determined by the activation pathway (Aatonen et al., 2014) . This suggests specific packaging of extracellular vesicles under different circumstances. Heijnen et al. showed that, upon activation, platelets predominantly release two types of extracellular vesicles: PMPs and exosomes (Heijnen et al., 1999) . PMPs, also called platelet microvesicles, are 0.1 to 1 m in diameter and are shed from the platelet plasma membrane (Sandberg et al., J o u r n a l P r e -p r o o f 1985). They carry cytoplasm, RNA and proteins of the parent cell that can be transferred to other cells, thereby affecting target cell function (Baj-Krzyworzeka et al., 2002; Janowska-Wieczorek et al., 2005 Rozmyslowicz et al., 2003) . Like platelets, PMPs carry a large range of bioactive molecules. Apart from factors involved in coagulation, cell adhesion and activation, these molecules include cytokines and chemokines, such as PF4 (Garcia et al., 2005) , which has been recently shown to promote neuronal differentiation in neural precursor cells (Leiter et al., 2019) . PMPs are heterogenous in membrane composition and molecular content (Dean et al., 2009 ), thereby mediating different functional effects. This heterogeneity is dictated by the stimulus which triggers the PMP generation (Milioli et al., 2015; Perez-Pujol et al., 2007; Shai et al., 2012) . However, the mechanisms by which selective packaging of PMPs occurs and how they release their biological material to mediate the function of the target cells remains unknown. Moreover, PMPs differ in size (Dean et al., 2009) , with smaller vesicles being suggested to enter more difficult regions, such as the brain tissue beyond the blood-brain barrier (Zaldivia et al., 2017) .
Platelets secrete exosomes
In addition to PMPs, platelets release exosomes, which are CD63 + , 40 to 100 nm diameter extracellular vesicles that derive from endosomal multivesicular bodies and -granules (Heijnen et al., 1999) . Exosomes have been shown to be an important mechanism of cellular communication for different types of adult stem cells, including neural stem cells . A recent review underlines the potential contribution of exosomes to the regulation of neural precursor cells in the neurogenic niches (Bátiz et al., 2016) . Previous studies in the context of brain injury showed that the systemic administration of exosomes released from mesenchymal stem cells into the tail vein of ischemic rats increased the number of proliferating immature new neurons in the lesion boundary zone, suggesting that mesenchymal stem cell-derived exosomes stimulate SVZ neurogenesis following stroke (Xin et al., 2013) . Likewise, such exosomes were shown to increase hippocampal neurogenesis in rats following traumatic brain injury (Zhang et al., 2015) . With platelet exosomes containing mainly, but not exclusively, α-granule contents (Heijnen et al., 1999) , including several neurogenesis-promoting molecules, platelet exosome release represents a potential J o u r n a l P r e -p r o o f path of communication between neural precursor cells and platelets after environmental stimulation.
Local, possibly receptor-mediated release of factors
Although extracellular vesicles can be released following platelet activation in response to peripheral stimulation, platelets themselves are small enough to travel within the brain microvasculature. One potential mechanism via which platelets could mediate brain function is through crosstalk with neural precursor cells. These precursor cells contact the microvasculature (Filippov et al., 2003; Moss et al., 2016) , a prerequisite that could allow communication with factors from the blood. A recent study showed that, following activation by paracrine signaling from other collagenactivated platelets, these cells can autonomously and actively migrate through the blood (Gaertner et al., 2017) . This suggests that platelets can fulfil site-specific, local actions. Therefore, platelets could be recruited to neurogenic sites by specific, as yet unknown, cues. Neurogenesis occurs in angiogenic niches (Palmer et al., 2000) and it has been demonstrated that platelets preferentially adhere to angiogenic vessels (Kisucka et al., 2006) . Although they have the capacity to locally enhance angiogenesis (Kisucka et al., 2006) , platelets could also stimulate neural precursor cells by depositing neurogenesis-stimulating factors in a localized manner. Moreover, pro-angiogenic effectors, which could be locally released by platelets, increase the permeability of the vessel wall (Patzelt and Langer, 2012) , providing a potential mechanism to facilitate the crossing of blood-derived factors into cells within the neurogenic niche. Changes in blood-brain barrier integrity occur under normal circumstances in the adult brain (Abbott, 2002; Zlokovic, 2008) , including after physical exercise (Sharma et al., 1991; Van der Borght et al., 2009 ). Under pathological conditions, for example following stroke and in experimental autoimmune encephalomyelitis (EAE)-induced mice, platelets have been found within neuronal tissue, outside the vasculature (Kocovski et al., 2019; Schleicher et al., 2015) . This indicates that their actions may not be restricted to the blood vessels, but that they could also migrate into the brain parenchyma to fulfil direct actions there (Kocovski et al., 2019; Schleicher et al., 2015) . However, it remains to be determined whether platelets have the capacity to alter the integrity of the blood-brain barrier at neurogenic sites under physiological conditions, such as following exercise. Platelets express a J o u r n a l P r e -p r o o f number of surface molecules, which allow them to directly interact with many cell types, including cells of the neurovascular unit, such as glial cells, endothelial cells and neurons (Hayon et al., 2013; Sotnikov et al., 2013) . More specifically, platelets bind CNS-specific glycolipid structures present in the lipid rafts of neuronal processes (Sotnikov et al., 2013) via which they promote the formation of new dendritic spines on these cells (Dukhinova et al., 2018) . Similar glycolipid structures are also present on neural precursor cells (Capela and Temple, 2002; Kaneko et al., 2011) . Although there are indications that platelets may directly communicate with neural precursor cells via a receptor-mediated interaction, the evidence is by no means conclusive.
Until further data confirming a direct interaction is presented, this remains speculative.
Plateletstherapeutic implications in neurodegenerative conditions?
In this perspective we have predominantly focused on the beneficial effects of healthy platelets on brain plasticity and function. However, platelet dysfunction has been implicated in several neurodegenerative diseases, such as Huntington's disease, Parkinson's disease and amyotrophic lateral sclerosis (as reviewed in Behari and Shrivastava, 2013) . Alterations in platelet function have also been implicated in inflammatory CNS diseases, such as multiple sclerosis, where more activated platelets are present in the blood of patients (Sheremata et al., 2008) . In the mouse EAE model of multiple sclerosis, platelets were recently shown to not only aggravate , but also to initiate the development of grey matter damage in the spinal cord (D'Souza et al., 2018) . Moreover, in the brain of EAE-induced mice, platelets infiltrated into the hippocampus, which was associated with the establishment of a neuroinflammatory environment due to platelet-neuron associations, but not with inflammatory cell infiltration, highlighting the driving role of platelets in the onset of the disease (Kocovski et al., 2019) . This effect as well as the increased anxiety-like behavior that is observed in EAE-induced mice, were ameliorated when the mice were depleted of platelets, suggesting that platelets act as a target to mitigate the effects of multiple sclerosis, including the subsequent neuropsychiatric symptoms observed in these patients (Kocovski et al., 2019) .
Platelets also exert an effect in Alzheimer's disease. They contain high levels of amyloid precursor protein (Li et al., 1994) and are equipped with the necessary J o u r n a l P r e -p r o o f machinery to produce its metabolites, such as amyloid-ß, which can be secreted from activated platelets (Li et al., 1998) . The ratio of platelet amyloid precursor protein isoforms was shown to be significantly different between controls and Alzheimer's disease patients and correlated with the cognitive decline in these patients, suggesting that platelets could also serve as a biomarker for the conversion from the state of mild cognitive impairment to Alzheimer's disease (Zainaghi et al., 2012) . Moreover, platelets isolated from an Alzheimer's disease mouse model were shown to contribute to neuroinflammation and vessel damage in the brains of healthy mice, with amyloidß-like immunoreactivity surrounding the damaged vessel sites, suggesting that amyloid-ß is released by the platelets at these sites (Kniewallner et al., 2018) . This is consistent with another study which reported that platelets promote the formation of amyloid-ß aggregates in cerebral vessels, and found that the number of vessels with plaques in APP23 transgenic Alzheimer's disease model mice was significantly reduced when these mice were treated for three months with clopidogrel, an inhibitor of platelet activation (Donner et al., 2016) . Moreover, the authors observed a trend towards reduced plaque formation in the hippocampus, one of the first areas affected by Alzheimer's disease (Donner et al., 2016) .
Despite platelet dysfunction being implicated in neurodegeneration, platelets and the factors they release are also emerging as potential therapeutic interventions for the treatment of several neurodegenerative conditions. Human platelet lysate represents a potential physiological treatment, which comprises a plethora of growth factors, including those with neuroprotective properties. In an attempt to establish human platelet lysate treatment in neurogenerative conditions, Gouel et al. used in vitro models of Parkinson's disease and amyotrophic lateral sclerosis and found that human platelet lysate supplementation prevented cell death (apoptosis and ferroptosis) by inducing Akt and MEK signaling in the cell lines, suggesting that neuronal loss can be reduced in those conditions (Gouel et al., 2017) . In another study, the human platelet lysate preparation was further optimized such that it was more concentrated in platelet neurotrophins and depleted of plasma proteins, which could cause adverse thrombotic effects following in vivo applications (Chou et al., 2017) .
When the optimized platelet lysate was administered intranasally into Parkinson's disease mice, clear protective effects on dopaminergic neurons were observed in the substantia nigra and the striatum (Chou et al., 2017) . Moreover, following this non- These examples highlight the impact that platelets can have on brain function, not only under physiological conditions but also in the context of disease processes. Importantly, both neurodegenerative diseases and normal aging are conditions that result in reduced brain plasticity, as well as alterations in blood composition, including a decreased platelet count with advancing age (Biino et al., 2013) . Thus, the role of platelets in facilitating crosstalk between the blood and the brain in order to regulate brain plasticity suggests a reservoir that could be harnessed for the development of therapeutic interventions to promote cognitive function in the human brain in aging and disease.
Conclusion
Multi-directional inter-organ crosstalk via the blood stream is essential to maintain homeostasis and allows the brain to respond and adapt to the environmental changes which occur throughout life. The impact that platelets have on brain cells highlights the fact that the role of peripheral blood-borne factors in the regulation of brain function in both pathological and physiological conditions should not be underestimated. Platelets influence neural precursor cells; however, the mechanism via which platelets communicate with cells within the brain parenchyma is unknown. Following activation, platelets can secrete bioactive molecules from granules (upper left), release microparticles (lower left) or exosomes (upper right), or directly interact via surface receptors expressed by neural precursor cells (lower right).
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